These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 34558846)

  • 1. Letter to the Editor: Reply to Autoimmune Hepatitis and Coronavirus Disease 2019: Disease Outcomes and Tacrolimus Use.
    Efe C; Wahlin S
    Hepatol Commun; 2022 Nov; 6(11):3272. PubMed ID: 34558846
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the Editor: Autoimmune Hepatitis and Coronavirus Disease 2019: Disease Outcomes and Tacrolimus Use.
    Ng AC
    Hepatol Commun; 2021 Oct; 5(10):1801-1802. PubMed ID: 34222740
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to: "Comment on "Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?"".
    Bril F; Fettig DM
    J Hepatol; 2021 Oct; 75(4):996-997. PubMed ID: 34146650
    [No Abstract]   [Full Text] [Related]  

  • 4. Comment on "Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?".
    Capecchi PL; Lazzerini PE; Brillanti S
    J Hepatol; 2021 Oct; 75(4):994-995. PubMed ID: 33964372
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter to the editor: "Autoimmune hepatitis after COVID-19 vaccination".
    Mungmunpuntipantip R; Wiwanitkit V
    Hepatology; 2022 Mar; 75(3):756. PubMed ID: 34797931
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter to the editor: Exacerbation of autoimmune hepatitis after COVID-19 vaccination.
    Cao Z; Gui H; Sheng Z; Xin H; Xie Q
    Hepatology; 2022 Mar; 75(3):757-759. PubMed ID: 34862637
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter to the editor: Autoimmune hepatitis after COVID-19 vaccination: Need for population-based epidemiological study.
    Suzuki Y; Kakisaka K; Takikawa Y
    Hepatology; 2022 Mar; 75(3):759-760. PubMed ID: 34904265
    [No Abstract]   [Full Text] [Related]  

  • 8. Is immunosuppression truly associated with worse outcomes in autoimmune hepatitis patients with COVID-19?
    Terziroli Beretta-Piccoli B; Lleo A
    Liver Int; 2022 Feb; 42(2):274-276. PubMed ID: 35092335
    [No Abstract]   [Full Text] [Related]  

  • 9. Autoimmune hepatitis triggered by COVID-19: A report of two cases.
    Kabaçam G; Wahlin S; Efe C
    Liver Int; 2021 Oct; 41(10):2527-2528. PubMed ID: 34478591
    [No Abstract]   [Full Text] [Related]  

  • 10. Autoimmune Hepatitis Following Vaccination for SARS-CoV-2 in Korea: Coincidence or Autoimmunity?
    Kang SH; Kim MY; Cho MY; Baik SK
    J Korean Med Sci; 2022 Apr; 37(15):e116. PubMed ID: 35437965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of patients with autoimmune liver disease during COVID-19 pandemic.
    Lleo A; Invernizzi P; Lohse AW; Aghemo A; Carbone M
    J Hepatol; 2020 Aug; 73(2):453-455. PubMed ID: 32283134
    [No Abstract]   [Full Text] [Related]  

  • 12. Autoimmune hepatitis following COVID-19 vaccination: True causality or mere association?
    Tan CK; Wong YJ; Wang LM; Ang TL; Kumar R
    J Hepatol; 2021 Nov; 75(5):1250-1252. PubMed ID: 34153398
    [No Abstract]   [Full Text] [Related]  

  • 13. Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?
    Bril F; Al Diffalha S; Dean M; Fettig DM
    J Hepatol; 2021 Jul; 75(1):222-224. PubMed ID: 33862041
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis.
    Efe C; Lammert C; Taşçılar K; Dhanasekaran R; Ebik B; Higuera-de la Tijera F; Calışkan AR; Peralta M; Gerussi A; Massoumi H; Catana AM; Purnak T; Rigamonti C; Aldana AJG; Khakoo N; Nazal L; Frager S; Demir N; Irak K; Melekoğlu-Ellik Z; Kacmaz H; Balaban Y; Atay K; Eren F; Alvares-da-Silva MR; Cristoferi L; Urzua Á; Eşkazan T; Magro B; Snijders R; Barutçu S; Lytvyak E; Zazueta GM; Demirezer-Bolat A; Aydın M; Heurgue-Berlot A; De Martin E; Ekin N; Yıldırım S; Yavuz A; Bıyık M; Narro GC; Kıyıcı M; Akyıldız M; Kahramanoğlu-Aksoy E; Vincent M; Carr RM; Günşar F; Reyes EC; Harputluoğlu M; Aloman C; Gatselis NK; Üstündağ Y; Brahm J; Vargas NCE; Güzelbulut F; Garcia SR; Aguirre J; Anders M; Ratusnu N; Hatemi I; Mendizabal M; Floreani A; Fagiuoli S; Silva M; Idilman R; Satapathy SK; Silveira M; Drenth JPH; Dalekos GN; N Assis D; Björnsson E; Boyer JL; Yoshida EM; Invernizzi P; Levy C; Montano-Loza AJ; Schiano TD; Ridruejo E; Wahlin S
    Liver Int; 2022 Mar; 42(3):607-614. PubMed ID: 34846800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: One or even several swallows do not make a summer.
    Bril F
    J Hepatol; 2021 Nov; 75(5):1256-1257. PubMed ID: 34384822
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to: "Both tacrolimus and mycophenylate mophetil should be considered second-line therapy for autoimmune hepatitis".
    Lohse AW; Sebode M; Vesterhus M
    J Hepatol; 2021 Mar; 74(3):755-756. PubMed ID: 33309116
    [No Abstract]   [Full Text] [Related]  

  • 17. Autoimmune Hepatitis Associated with COVID-19 Infection - A Diagnostic and Therapeutic Dilemma.
    Rajendiran G; Cowman B; Erickson K; Oliver T; Manatsathit W
    S D Med; 2020 Nov; 73(11):528-532. PubMed ID: 33684272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune hepatitis following SARS-CoV-2 vaccine: May not be a casuality.
    Rocco A; Sgamato C; Compare D; Nardone G
    J Hepatol; 2021 Sep; 75(3):728-729. PubMed ID: 34116081
    [No Abstract]   [Full Text] [Related]  

  • 19. SARS-CoV-2 Vaccine Response in Patients With Autoimmune Hepatitis.
    Schneider L; Schubert L; Winkler F; Munda P; Winkler S; Tobudic S
    Clin Gastroenterol Hepatol; 2022 Sep; 20(9):2145-2147.e2. PubMed ID: 35487452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune hepatitis triggered by COVID-19.
    Montón Rodríguez C; Navarro Cortés P; Lluch García P; Mínguez Pérez M
    Rev Esp Enferm Dig; 2022 Jan; 114(1):64-65. PubMed ID: 34015933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.